| Preferred Therapy and Duration Recommendation from the U.S. Centers for Disease Control and Prevention |
Because of the lack of controlled trial data on the use of antiviral agents against HBV in HIV/HBV co-infected patients, none of the current therapy can be recommended as preferred regimen |
| For full recommendations, click here |